Senior Director, SOX Compliance

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2...

Lugar: Waltham, MA | 14/11/2025 03:11:39 AM | Salario: S/. No Especificado | Empresa: Madrigal

Executive Director, Legal and Compliance Operations

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... consideration for employment without regard to race, ethnicity, color, religion, sex gender identity, sexual orientation, national...

Lugar: Conshohocken, PA | 14/11/2025 01:11:39 AM | Salario: S/. No Especificado | Empresa: Madrigal

Senior Director, Global Safety Physician

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... gender identity, sexual orientation, national origin, age, disability, protected veteran or disabled status...

Lugar: Conshohocken, PA | 11/11/2025 19:11:33 PM | Salario: S/. No Especificado | Empresa: Madrigal

Senior Director, Compensation Partner

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... consideration for employment without regard to race, ethnicity, color, religion, sex gender identity, sexual orientation, national...

Lugar: Waltham, MA | 07/11/2025 19:11:28 PM | Salario: S/. No Especificado | Empresa: Madrigal

Registered Nurse (RN) - Operations Coordinator - Per Diem

: 00004024 CLINICAL NURSE II Job Level: F2 Duke is an Equal Opportunity Employer committed to providing employment opportunity..., national origin, race, religion, sex (including pregnancy and pregnancy related conditions), sexual orientation or military...

Lugar: Raleigh, NC | 01/11/2025 18:11:23 PM | Salario: S/. No Especificado | Empresa: Duke University